Insulin glulisine, human

APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear.

Drug facts

Used for: APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

What it is used for

APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. APIDRA is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Insulin glulisine, human; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/insulin-glulisine-human
APA 7th: sofidex. (2026, August 3). Insulin glulisine, human. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/insulin-glulisine-human
AMA 11th: Insulin glulisine, human. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/insulin-glulisine-human

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.